Aandeel GANGAPHARM6 GANGA PHARMACEUTICALS LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Ganga Pharmaceuticals Limited

Aandelen

GANGAPHARM6

INE615T01017

Beurs gesloten - Bombay S.E.
Andere beurzen
 12:00:55 24-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
24,67 INR -.--% Intraday-grafiek van Ganga Pharmaceuticals Limited -.--% -13,41%
16/05 Ganga Pharmaceuticals Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 maart 2024 CI
2023 Ganga Pharmaceuticals Limited rapporteert resultaten voor het halfjaar dat eindigde op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Ganga Pharmaceuticals Limited announced that it has received INR 17.0625 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp
Ganga Pharmaceuticals Limited announced that it expects to receive INR 21 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp
Ganga Pharmaceuticals Board to Consider Issuing Equity, Convertible Warrants to Raise Funds
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2022
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2021
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2020
Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
Ganga Pharmaceuticals Limited Announces Management Changes
Ganga Pharmaceuticals Limited Announces the Appointment and Re-Designation of Sanjay Kulkarni as Executive Director
Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019
874,550 equity shares of Ganga Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 23-FEB-2019.
Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2018
Ganga Pharmaceuticals Limited Appoints Anagh B. Sharma as Chief Financial Officer
Ganga Pharmaceuticals Limited Announces Resignation of Ganesh Jyothimani Paradeshi, Chief Financial Officer
Ganga Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2018
Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2017
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers GANGAPHARM6
  4. Nieuws Ganga Pharmaceuticals Limited
  5. Andere talen